Literature DB >> 7643542

Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.

H P Hansen1, P Rossing, L Tarnow, F S Nielsen, B R Jensen, H H Parving.   

Abstract

Initiation of antihypertensive treatment (AHT) in hypertensive insulin-dependent diabetic (IDDM) patients with diabetic nephropathy (DN) induces a faster initial (0 to 6 months) and a slower subsequent (6 months to end of observation) decline in GFR [delta GFR (ml/min/month) approximately 1.5 vs. 0.35]. Whether this initial phenomenon is reversible (hemodynamic) or irreversible (structural damage) after prolonged AHT is not known. To elucidate these mechanisms we investigated 42 hypertensive IDDM patients (16F/26M, age 40 +/- 7 years, mean +/- SD) with DN receiving AHT (angiotensin converting enzyme inhibition, N = 30) for 6 (2 to 15) years [median (range)]. GFR (ml/min/1.73 m2), arterial blood pressure (BP, mm Hg) and albuminuria (mg/24 hr) were measured the last day on AHT and one month after withdrawal of AHT. The measured variables were all significantly elevated after withdrawal of AHT: GFR [mean(SEM)] from 76(4) to 81(4) (P < 0.0001), BP [mean(SEM)] from 140/82 (2/1) to 151/89 (2/1) (P < 0.0005) and albuminuria [geometric mean (antilog SEM)] from 704 (1.2) to 1122 (1.2) (P < 0.0001). A correlation between relative rise in systolic blood pressure (delta Sys%) and relative change in GFR (delta GFR%) was found (r = 0.44, P < 0.005). Our results render some support of the hypothesis that the faster initial decline in GFR is due to a functional (hemodynamic) effect of AHT, which does not attenuate over time, while the subsequent slower decline reflects the beneficial effect on progression of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7643542     DOI: 10.1038/ki.1995.238

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

Review 1.  The clinical significance of hyperfiltration in diabetes.

Authors:  G Jerums; E Premaratne; S Panagiotopoulos; R J MacIsaac
Journal:  Diabetologia       Date:  2010-05-23       Impact factor: 10.122

Review 2.  Renal failure and ACE inhibition: how much is too much?

Authors:  M-L Gross; M Adamczak; E Ritz
Journal:  Z Kardiol       Date:  2005-02

3.  Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index.

Authors:  Arjan J Kwakernaak; Dorien M Zelle; Stephan J L Bakker; Gerjan Navis
Journal:  J Am Soc Nephrol       Date:  2013-04-11       Impact factor: 10.121

Review 4.  Renal protection and antihypertensive drugs: current status.

Authors:  A Salvetti; P Mattei; I Sudano
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

5.  Discontinuation of RAAS Inhibition in Children with Advanced CKD.

Authors:  Sophie M van den Belt; Hiddo J L Heerspink; Marietta Kirchner; Valentina Gracchi; Daniela Thurn-Valsassina; Aysun K Bayazit; Anna Niemirska; Nur Canpolat; Ipek Kaplan Bulut; Karolis Azukaitis; Ali Duzova; Justine Bacchetta; Rukshana Shroff; Dusan Paripovic; Zeynep Birsin Özçakar; Kibriya Fidan; Hakan Erdogan; Jutta Gellermann; Elke Wühl; Dick de Zeeuw; Anette Melk; Uwe Querfeld; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-06       Impact factor: 8.237

Review 6.  The effect of RAAS blockade on the progression of diabetic nephropathy.

Authors:  Sara S Roscioni; Hiddo J Lambers Heerspink; Dick de Zeeuw
Journal:  Nat Rev Nephrol       Date:  2013-12-03       Impact factor: 28.314

7.  Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan.

Authors:  Liffert Vogt; Femke Waanders; Frans Boomsma; Dick de Zeeuw; Gerjan Navis
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

8.  Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients.

Authors:  Macaulay A C Onuigbo; Nnonyelum T C Onuigbo
Journal:  Int Urol Nephrol       Date:  2008-01-15       Impact factor: 2.370

Review 9.  Management of Presumed Acute Kidney Injury during Hypertensive Therapy: Stay Calm and Carry on?

Authors:  Teresa K Chen; Chirag R Parikh
Journal:  Am J Nephrol       Date:  2020-01-15       Impact factor: 3.754

Review 10.  Does the temporary decrease in the estimated glomerular filtration rate (eGFR) after initiation of mineralocorticoid receptor (MR) antagonist treatment lead to a long-term renal protective effect?

Authors:  Atsuhisa Sato
Journal:  Hypertens Res       Date:  2019-09-06       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.